Related Experiment Video

Updated: May 9, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Clinical behavior of HPV-negative and HPV-positive vulvar cancers

Yevgeniya J Ioffe1, L Stewart Massad

  • 1Washington University in St Louis School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, USA.

Gynecologic Oncology
|July 11, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Related Experiment Videos

Last Updated: May 9, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Articles linked to this work by shared authors, journal, and citation graph.

Real-world outcomes after Mirvetuximab Soravtansine treatment for recurrent ovarian Cancer: Results from a university setting.

Gynecologic oncology reports·2026

Cancer cell-intrinsic type 1 interferon: production, signaling, and outcomes within sex-biased, female malignancies.

Molecular oncology·2026

Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancer.

Molecular oncology·2026

Correlation of patient reported outcomes and physical exam screening for pelvic floor dysfunction: An opportunity for improved quality of life during chemoradiotherapy for cervical cancer.

Gynecologic oncology reports·2026

Real-world outcomes after pembrolizumab treatment for cervical cancer: Results from a university setting.

Gynecologic oncology reports·2025

Diverse case series of granulomatous peritonitis mimicking advanced ovarian cancer.

Gynecologic oncology reports·2025

Planning and feasibility of phase III surgical trials in gynecologic oncology.

Gynecologic oncology·2026

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Gynecologic oncology·2026

Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Gynecologic oncology·2026

Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis.

Gynecologic oncology·2026

Molecular characterization of NSMP endometrial cancer and its relevance for treatment.

Gynecologic oncology·2026

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Gynecologic oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us